Featured Post from VCU College of Engineering

At VCU, engineering and pharmacy join forces to make inhaled medications more effective for infants and children

Oct 31, 2019

3 min

Pharmaceutical aerosols are painless, fast-acting and less likely to cause side effects than medicines delivered via pills or injections. Yet inhaled therapies are often avoided because of the challenges associated with targeting how aerosol particles are deposited within the lung.


“Current inhalers produce fairly large particles, so approximately 90 percent of the medication gets lost in the mouth and throat. It’s swallowed and wasted. This prevents many medications from being delivered through the inhalation route, even though there are a number of advantages to be gained, such as improved efficacy and reduced side effects,” said Worth Longest, Ph.D., the Louis S. and Ruth S. Harris Exceptional Scholar Professor in the Department of Mechanical and Nuclear Engineering in the VCU College of Engineering.


Simply making the particles smaller isn’t a solution.


“The problem with making the particles smaller is that they go in really well — but they also come straight back out during exhalation,” said Michael Hindle, Ph.D., the Peter R. Byron Distinguished Professor in the VCU School of Pharmacy.

With three National Institutes of Health R01 grants totaling more than $7 million, Longest and Hindle are applying a combined engineering and pharmaceutical approach to make inhaled medications more effective and available.


In “High-Efficiency Aerosol Delivery Using the Excipient Enhanced Growth Concept: A Human Proof of Concept Study,” Longest and Hindle have created a novel platform that produces particles that are tiny when they enter the lungs — but grow in size as they travel down the warm, humid airways. This platform comprises a device that uses a mixer-heater to produce tiny particles, about one-fifth the size of those from conventional inhalers.


With this delivery concept, a pharmaceutical powder or liquid is enhanced with a hygroscopic excipient, essentially a substance that attracts water. “Your lungs are full of water,” Hindle said. “So if you put something inside your lungs that likes water, it’s going to swell and grow in size and not be expelled.” Using sodium chloride — salt — as the hygroscopic excipient, they have tested their system in vitro.

The results have been promising.


“We’ve flipped the needle,” Longest said. “Previously, only 10 percent of the initial dose would reach the lung, and that 10 percent was poorly targeted within different lung regions. With our approach, you can get 90 percent in and distribute that 90 percent evenly, or target a specific lung region.”


The researchers will begin testing their method on adults in two human proof-of-concept trials beginning in late 2019 and early 2020.


In two separate, but related, NIH studies, Longest and Hindle are adapting this concept for patients ranging in age from newborn to six. Each project proposes a device approximately the size of a lipstick tube that contains a pediatric formulation (liquid or powder) enhanced with a hygroscopic excipient. There are currently no inhalers on the market specifically designed for children or infants, even though their inhaling patterns and volumes differ from those of adults. Pediatric patients therefore must use adult-sized devices.


One study focuses on targeted lung delivery of the antibiotic tobramycin to children with cystic fibrosis, a population prone to respiratory infection because of overproduction of mucus in the lungs. Pediatric cystic fibrosis patients with lung infections usually receive the medication via, 20-minute nebulizer treatments daily, sometimes up to four per day.


Longest and Hindle’s proposed alternative is a pediatric dry powder inhaler that is fast and easy to use. Because its particles are engineered to reach the deep lung, it is expected to eradicate infection more efficiently because there is less risk of resistant strains of bacteria forming in undertreated regions of the lung.


The other study focuses on delivery of surfactant aerosols to premature infants. Surfactant is a substance found in healthy lungs that keeps the tissue supple enough to expand and contract properly. The respiratory system is among the last to develop in utero, so in newborns and preemies, this substance is sometimes not fully developed — or not present at all.


When these infants experience severe respiratory distress, the current protocol is to intubate and administer large doses of liquid surfactant to the lung by way of the throat. This highly invasive and potentially dangerous procedure causes distress and blood pressure fluctuations. In this third NIH-funded study, the researchers are also developing a tiny, small volume nebulizer and a dry powder inhaler for efficient, noninvasive respiratory support for infants.





You might also like...

Check out some other posts from VCU College of Engineering

2 min

National Science Foundation funds research into quantum material-based computing architecture at the VCU College of Engineering

Supporting the development of advanced computing hardware, the National Science Foundation (NSF) awarded Supriyo Bandyopadhyay, Ph.D., Commonwealth Professor in the Department of Electrical and Computer Engineering at the Virginia Commonwealth University (VCU) College of Engineering with more than $300,000 to develop processor-in-memory architecture using quantum materials. “This is one of the first mainstream applications of quantum materials that have unusual and unique quantum mechanical properties,” Bandyopadhyay said. “Quantum materials have been researched for more than a decade and yet there is not a single mainstream product in the market that utilizes them. We want to change that.” The four-year project, titled “Collaborative Research, Foundations of Emerging Technologies: PRocessor In Memory Architecture based on Topological Electronics (PRIMATE),” aims to advance computing hardware and artificial intelligence by integrating topological insulators and magnetic materials. Topological insulators are a special material with an electrically conductive surface and an insulated interior. They have special quantum mechanical properties like “spin-momentum locking,” which ensures the quantum mechanical spin of an electron-conducting current on the surface of the material is always perpendicular to the direction of motion.This marks the first time such quantum materials will be used in a processor-in-memory system. “We place a magnet on top of a topological insulator,” Bandyopadhyay said. “We then change the magnetization of the magnet by applying mechanical strain on it. That changes the electrical properties of the topological insulator via a quantum mechanical interaction known as exchange interaction. This change in the electrical properties can be exploited to perform the functions of a processor-in-memory computer architecture. The advantage is that this process is fast and extremely energy-efficient.” If successful, this approach could reduce energy use and dramatically speed up computing by moving data processing into the memory itself. It addresses the longstanding “memory bottleneck,” the slowdown caused by computers constantly needing to move data back and forth between processor and memory. These efficiencies could make advanced AI more efficient and accessible, paving the way for the first commercially viable applications of quantum materials.. The research is a collaboration with University of Virginia professors Avik Ghosh and Joseph Poon. A VCU Ph.D. student will work on the project and receive training in fabrication, characterization and measurement techniques, preparing them to lead in the rapidly evolving field of computing hardware.

2 min

American Nuclear Society names Lane Carasik, Ph.D., as one of its “40 Under 40”

Recognized as an emerging leader in the nuclear science and engineering field, Lane Carasik, Ph.D., assistant professor in the Department of Mechanical and Nuclear Engineering, was recently acknowledged by the American Nuclear Society as one of its top “40 Under 40.” “It is a huge honor to receive this acknowledgement from my professional community,” said Carasik. “I feel it is a reflection of the amazing nuclear engineering activities I’ve gotten the opportunity to pursue before and during my time at the VCU College of Engineering.” The list, featured in the most recent issue of Nuclear News magazine, celebrates young professionals who are driving innovation and shaping the future of nuclear science and technology. Created to spotlight a new generation of nuclear professionals, the “40 Under 40” program highlights those who are advancing technical fields, from advanced reactor deployment to AI applications and national security, while actively engaging the public, mentoring peers and advocating for nuclear’s role to achieve energy independence and security. “Dr. Carasik’s research efforts, together with his support for students and their own research goals, exemplifies the best qualities of the VCU College of Engineering,” said Arvind Agarwal, Ph.D., chair of the Department of Mechanical and Nuclear Engineering, “integrating research and teaching at the core of everything he does, from classroom and lab work to community outreach.” Carasik was selected for the “40 Under 40” from hundreds of candidates across the United States. Mentoring his first three Ph.D. graduates, Arturo Cabral, Connor Donlan and James Vulcanoff, is one of Carasik’s proudest achievements. He was also honored by the American Society of Mechanical Engineers (ASME) as a rising star in mechanical engineering in 2024 This builds off Carasik receiving the highly competitive and prestigious Department of Energy (DOE) Early Career Research Award ($875k split over five years) in 2023 to support his work on molten salt based fusion energy systems similar to Commonwealth Fusion Systems’ ARC technology. Carasik’s Fluids in Advanced Systems and Technology (FAST) research group, is a computational and experimental thermal hydraulics group focused on enabling the development of advanced energy systems and critical isotope production methods. Legendary physicist Enrico Fermi was an early inspiration to Carasik during his undergraduate studies. Fermi’s expertise mirrored Carasik’s interests, and the physicist’s impact on the field of nuclear engineering was motivating. As an established nuclear engineering faculty member, Carasik seeks to make a lasting impact on the field and the people in it. His ’s long-term goal is earning membership in the National Academies of Sciences, Engineering and Medicine.

2 min

VCU College of Engineering’s Michael McClure, Ph.D., named chair of Orthopaedic Research Society’s Skeletal Muscle Section

Michael McClure, Ph.D., associate professor from the Department of Biomedical Engineering and affiliate faculty in the Department of Orthopaedic Surgery and in the Institute for Engineering and Medicine, has been named chair of the Orthopaedic Research Society’s (ORS) newly launched Skeletal Muscle Section. The section began in August 2025, building on research interest groups and symposia to create a dedicated home for skeletal muscle studies within ORS. Its mission is to advance collaboration, innovation, education and translation in this field. Skeletal muscle disorders cause disability, chronic pain and high health care costs. Severe injuries and degenerative diseases, such as muscular dystrophies, remain difficult to treat. The section will strengthen research in muscle development, aging, trauma, disuse and disease. This work will expand the basic understanding of and identify therapeutic targets to restore function. In its first year, the section will measure success through increased skeletal muscle abstracts at the 2027 ORS Annual Meeting, growth in ORS membership and active participation in section programs. “We are thrilled to launch the Skeletal Muscle Section,” McClure said. “This home for translational muscle research will build on ORS progress over the past 10 years, help recruit new members and foster an environment that connects multiple areas of orthopaedic science.” McClure’s commitment to this work is shaped by his family’s experience with neuromuscular diseases, witnessing the impact of war-related injuries on patients’ quality of life from the Richmond Veterans Affairs Medical Center, and the momentum of translational discovery. Learn more about the ORS Skeletal Muscle Section.

View all posts
Powered by